A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size

DWIVEDI, ASHOK K.; GORNALUSSE, GERMÁN G.; SIEGEL, DAVID A.; BARBEHENN, ALTON; THANH, CASSANDRA; HOH, REBECCA; HOBBS, KRISTEN S.; PAN, TONY; GIBSON, ERICA A.; MARTIN, JEFFREY; HECHT, FREDERICK; PILCHER, CHRISTOPHER; MILUSH, JEFFREY; BUSCH, MICHAEL P.; STONE, MARS; HUANG, MEEI-LI; REPPETTI, JULIETA; VO, PHUONG M.; LEVY, CLAIRE N.; ROYCHOUDHURY, PAVITRA; JEROME, KEITH R.; HLADIK, FLORIAN; HENRICH, TIMOTHY J.; DEEKS, STEVEN G.; LEE, SULGGI A.

PLOS PATHOGENS

PUBLIC LIBRARY SCIENCE

Año: 2023 vol. 19

1553-7366

The major barrier to an HIV cure is the HIV reservoir: latently-infected cells that persist despite effective antiretroviral therapy (ART). There have been few cohort-based studies evaluating host genomic or transcriptomic predictors of the HIV reservoir. We performed host RNA sequencing and HIV reservoir quantification (total DNA [tDNA], unspliced RNA [usRNA], intact DNA) from peripheral CD4+ T cells from 191 ART-suppressed people with HIV (PWH). After adjusting for nadir CD4+ count, timing of ART initiation, and genetic ancestry, we identified two host genes for which higher expression was significantly associated with smaller total DNA viral reservoir size, P3H3 and NBL1, both known tumor suppressor genes. We then identified 17 host genes for which lower expression was associated with higher residual transcription (HIV usRNA). These included novel associations with membrane channel (KCNJ2, GJB2), inflammasome (IL1A, CSF3, TNFAIP5, TNFAIP6, TNFAIP9, CXCL3, CXCL10), and innate immunity (TLR7) genes (FDR-adjusted q